Kelly Sanderson Schrems has been with AbbVie since 2013. Over the last decade she’s held a number of roles beginning with product manager on the neuroscience team. In 2020, she joined Pharmacyclics’ lymphoma and leukemia team as the director of CLL HCP marketing and was later appointed to her current role, head of marketing for the AbbVie oncology franchise A team. The final promotion tripled her oversight and leadership responsibilities, covering a full life-cycle portfolio of hematological products.
The speed with which Schrems has moved up the ranks at AbbVie is due to her unwavering focus. She is, her colleagues say, not motivated by individual accolades or recognition, but instead by a passionate dedication to progress. This commitment is evident in her consistent efforts to elevate the organization and improve patient outcomes.
A devoted mother, she says her young son inspires her to navigate the delicate work-life balance.
